Does Rallies show Form 4 insider transactions for ACA?

Yes. Rallies tracks ACA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ACA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ACA. It does not provide personalized investment advice.

ACA (Arcosa, Inc. Common Stock) Stock Analysis - Insider Trades

Arcosa, Inc. Common Stock (ACA) is a publicly traded Industrials sector company. As of May 21, 2026, ACA trades at $120.24 with a market cap of $6.00B and a P/E ratio of 26.33. ACA moved +2.48% today. Year to date, ACA is +10.45%; over the trailing twelve months it is +37.65%. Its 52-week range spans $68.11 to $135.58. Analyst consensus is strong buy with an average price target of $131.25. Rallies surfaces ACA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ACA stock inside the company?

Recent ACA insider activity includes Stevenson Bryan sold 4.00K, Cole Kerry S sold 7.97K, Collins Jesse E. Jr. sold 4.47K, Collins Jesse E. Jr. sold 4.15K, and Hurst Eric D sold 835. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ACA Key Metrics

Key financial metrics for ACA
Metric	Value
Price	$120.24
Market Cap	$6.00B
P/E Ratio	26.33
EPS	$4.54
Dividend Yield	0.05%
52-Week High	$135.58
52-Week Low	$68.11
Volume	0
Avg Volume	0
Revenue (TTM)	$2.82B
Net Income	$222.60M
Gross Margin	22.77%

Recent ACA Insider Trades

Stevenson Bryan sold 4.00K (~$396.08K) on Aug 12, 2025.
Cole Kerry S sold 7.97K (~$762.90K) on Aug 11, 2025.
Collins Jesse E. Jr. sold 4.47K (~$384.21K) on Jun 17, 2025.
Collins Jesse E. Jr. sold 4.15K (~$360.18K) on Jun 17, 2025.
Hurst Eric D sold 835 (~$73.96K) on May 15, 2025.

Latest ACA News

Arcosa rises as raised 2026 guidance and new $146 target lift sentiment — May 6, 2026
Arcosa jumps as raised 2026 outlook and post-barge-sale deleveraging keep bid under shares — May 5, 2026
Arcosa jumps as Q1 beat and higher 2026 outlook lift sentiment — May 4, 2026
Arcosa drops despite raised 2026 guidance as post-barge reset drives selling — May 1, 2026
Arcosa jumps on Q1 2026 earnings release, with fresh 5.24% Vanguard stake filing — Apr 30, 2026

ACA Analyst Consensus

4 analysts cover ACA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $131.25.

Common questions about ACA

Who is trading ACA stock inside the company?: Recent ACA insider activity includes Stevenson Bryan sold 4.00K, Cole Kerry S sold 7.97K, Collins Jesse E. Jr. sold 4.47K, Collins Jesse E. Jr. sold 4.15K, and Hurst Eric D sold 835. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ACA?: Yes. Rallies tracks ACA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ACA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ACA. It does not provide personalized investment advice.